AI Speeds Drug Ideas But Creates Costly Testing Bottlenecks - Bloomberg.com

AI can generate drug candidates faster, but pharmaceutical companies still face expensive and time-consuming testing phases. This affects drug development timelines and costs that ultimately impact patients and healthcare.